Literature DB >> 22994217

Pathobiology of injury after stroke: the neurovascular unit and beyond.

Ulrich Dirnagl1.   

Abstract

Throughout the history of research on stroke pathophysiology, focus has shifted from purely vascular concepts to the insight that a complex interplay of biochemical and molecular mechanisms involving practically any cell type of the brain ("neurovascular unit") partakes in either salvage or demise of the tissue after a stroke. In addition, it was realized that peripheral immune cells play important roles, not only after their invasion into the brain but also because of stroke-induced effects on the immune system that can result in infections. Indeed, outcome of stroke patients is not only dictated by nonmodifiable factors, such as severity of stroke, age, or premorbidity, but also by modifiable factors largely related to medical complications, such as infections and possibly sarcopenia. The highly successful concept of stroke units attests to the benefits of treating stroke comprehensively. Breakthroughs in improving outcome after stroke will only result from approaches that target not only the brain, but also systemic effects of stroke.
© 2012 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22994217     DOI: 10.1111/j.1749-6632.2012.06691.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  75 in total

1.  The protective effect of epoxyeicosatrienoic acids on cerebral ischemia/reperfusion injury is associated with PI3K/Akt pathway and ATP-sensitive potassium channels.

Authors:  You-Yang Qu; Mei-Yan Yuan; Yu Liu; Xing-Jun Xiao; Yu-Lan Zhu
Journal:  Neurochem Res       Date:  2014-11-04       Impact factor: 3.996

Review 2.  Neuronal AChE splice variants and their non-hydrolytic functions: redefining a target of AChE inhibitors?

Authors:  M Zimmermann
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

Review 3.  Mechanisms of neurovascular dysfunction in acute ischemic brain.

Authors:  Y Terasaki; Y Liu; K Hayakawa; L D Pham; E H Lo; X Ji; K Arai
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

4.  Stroke-induced brain parenchymal injury drives blood-brain barrier early leakage kinetics: a combined in vivo/in vitro study.

Authors:  Mélanie Kuntz; Caroline Mysiorek; Olivier Pétrault; Maud Pétrault; Rustem Uzbekov; Régis Bordet; Laurence Fenart; Roméo Cecchelli; Vincent Bérézowski
Journal:  J Cereb Blood Flow Metab       Date:  2013-10-02       Impact factor: 6.200

5.  TGF-β2/Smad3 Signaling Pathway Activation Through Enhancing VEGF and CD34 Ameliorates Cerebral Ischemia/Reperfusion Injury After Isoflurane Post-conditioning in Rats.

Authors:  Li Peng; Jiangwen Yin; Sheng Wang; Mingyue Ge; Ziwei Han; Yan Wang; Meng Zhang; Liping Xie; Yan Li
Journal:  Neurochem Res       Date:  2019-09-25       Impact factor: 3.996

Review 6.  The High Cost of Stroke and Stroke Cytoprotection Research.

Authors:  Paul A Lapchak; John H Zhang
Journal:  Transl Stroke Res       Date:  2016-12-30       Impact factor: 6.829

7.  Neuroprotection and vasculoprotection using genetically targeted protease-ligands.

Authors:  Padmesh S Rajput; Jessica A Lamb; Jose Á Fernández; Jilin Bai; Benedict R Pereira; I-Farn Lei; Jennifer Leung; John H Griffin; Patrick D Lyden
Journal:  Brain Res       Date:  2019-03-14       Impact factor: 3.252

Review 8.  Neuroimmune Response in Ischemic Preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

Review 9.  The effects of hypertension on the cerebral circulation.

Authors:  Paulo W Pires; Carla M Dams Ramos; Nusrat Matin; Anne M Dorrance
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

Review 10.  The evolving role of neuro-immune interaction in brain repair after cerebral ischemic stroke.

Authors:  Xin Wang; Wei Xuan; Zi-Yu Zhu; Yan Li; Hao Zhu; Ling Zhu; Dan-Yun Fu; Li-Qun Yang; Pei-Ying Li; Wei-Feng Yu
Journal:  CNS Neurosci Ther       Date:  2018-10-22       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.